Sugi Predict

Sugi Predict / Compounds / SCHEMBL30980682

SCHEMBL30980682

SCHEMBL30980682

CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1CCCOCCOCCNC(=O)NCCCC(C)(CCCNC(=O)NCCOCCOCCC[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O)NC(=O)NCCOCCOCCOCCNC(=O)c1ccc(N2C(=O)C=CC2=O)cc1

nearest known ligand 0.35

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 3/20 0.35
▸ CA2 P00918 3/20 0.35
▸ CA9 Q16790 3/20 0.35
▸ CA12 O43570 2/20 0.35
▸ CA14 Q9ULX7 2/20 0.35
▸ OGA O60502 11/20 0.33
▸ HEXB P07686 8/20 0.32
▸ MDK P21741 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30980744 0.93 CA1 (0.39) CA1CA2CA9CA12CA14
SCHEMBL30980568 0.82 MAPK1 (0.38) OGAHEXBMDK
SCHEMBL30980784 0.82 MAPK1 (0.38) OGAHEXBMDK
SCHEMBL30980664 0.79 LMNA (0.41) —
SCHEMBL30980703 0.79 B4GALT1 (0.38) CA1CA2CA9CA12CA14
SCHEMBL30980577 0.78 MAPK1 (0.36) OGAHEXBMDK
SCHEMBL30980709 0.77 MAPK1 (0.41) OGAHEXBMDK
SCHEMBL30980775 0.76 MAPK1 (0.38) OGAMDK
SCHEMBL30980659 0.75 LMNA (0.41) —
SCHEMBL30980642 0.73 MAPK1 (0.43) CA1CA2CA9MDK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
EP-4651901-A1 CYCLING LYSOSOMAL TARGETING ANTIBODY CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
WO-2025035040-A1 LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF MUSCLE-SPECIFIC KINASE AUTOANTIBODIES LYCIA THERAPEUTICS, INC. (US) 2025-02-13 — — WO disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 — — WO disclosed
Send feedback